Cis-platinum chemotherapy for ocular basal cell carcinoma.
AUTOR(ES)
Morley, M.
RESUMO
We have used intravenous cis-platinum chemotherapy in the treatment of three patients with basal cell carcinoma of the lid extending into the orbit. Cis-platinum chemotherapy caused a reduction in tumour size and thereby delayed surgery in all cases. It allowed for local resection in one case, appeared to delay a patient's exenteration in a second case, and was used prior to radiotherapy in a third case. While not curative, cis-platinum may be useful as an adjuvant to decrease tumour mass prior to local excision and for patients who refuse or must delay exenteration.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1042405Documentos Relacionados
- Lability of monofunctional cis-platinum adducts: role of DNA double helix.
- Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence.
- Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.
- Effect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model.
- Immunosuppression with cis-Platinum (II) Diammino-dichloride: Effect on Antibody Plaque-Forming Spleen Cells